SRX Global Inc. (SRXH)
| Market Cap | 34.35M +145.5% |
| Revenue (ttm) | n/a |
| Net Income | -60,000 |
| EPS | n/a |
| Shares Out | 19.52M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | $0.05 (2.84%) |
| Ex-Dividend Date | Jul 22, 2026 |
| Volume | 166,324 |
| Open | 1.770 |
| Previous Close | 1.800 |
| Day's Range | 1.765 - 1.820 |
| 52-Week Range | 0.960 - 42.612 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 13, 2026 |
About SRXH
SRX Global Inc. operates an AI-driven platform focused on generating long-term shareholder value through investments in high-conviction operating companies, strategic assets, and technology-enabled opportunities. It leverages proprietary technology, data analytics, and disciplined capital allocation to identify and manage investments across various sectors. The company is based in Tampa, Florida.
Financial Performance
Financial StatementsNews
SRX Global Inc. Announces Fiscal Third Quarter 2026 Financial Results
Net Asset Value ("NAV") of $62.9 million , or $3.22 per Common Share, Exceeding Preliminary Estimate of $3.07 per Share 1 Ended the Quarter with $36.7 million of Cash, Cash Equivalents and Restricted...
SRX Global to Host Fiscal Third Quarter 2026 Conference Call on August 13 at 4:30 p.m. ET
NORTH PALM BEACH, Fla., Aug. 06, 2026 (GLOBE NEWSWIRE) -- SRX Global Inc. (NYSE American: SRXH) (the “Company”, or “SRX”), an AI-enabled platform dedicated to generating long-term shareholder value th...
SRX Global acquires stake in Vistagen
SRX Global (SRXH) announced that it has acquired a stake in Vistagen (VTGN). The company said it views Vistagen shares as undervalued and welcomes constructive engagement with its leadership team…
SRX Global Acquires Stake in Vistagen Therapeutics (NASDAQ: VTGN)
NORTH PALM BEACH, Fla., Aug. 04, 2026 (GLOBE NEWSWIRE) -- SRX Global Inc. (NYSE American: SRXH) (the “Company”, or “SRX”), an AI-enabled platform dedicated to generating long-term shareholder value th...
SRX Global Portfolio Company Smartkem, Inc. (NASDAQ: SMTK) Announces Merger
NORTH PALM BEACH, Fla., Aug. 03, 2026 (GLOBE NEWSWIRE) -- SRX Global Inc. (NYSE American: SRXH) (the “Company”, or “SRX”), an AI-enabled platform dedicated to generating long-term shareholder value th...
SRX Global Acquires Shares in Jersey Mike's $1 Billion Initial Public Offering
NORTH PALM BEACH, Fla., July 30, 2026 (GLOBE NEWSWIRE) -- SRX Global Inc. (NYSE American: SRXH) (the “Company”, or “SRX”), an AI-enabled platform dedicated to generating long-term shareholder value th...
SRX Global Regains Full Compliance with NYSE American Listing Standards
Company Resolves Section 1003(a)(i) and (ii) Deficiencies; Compliance Indicator to Be Removed Company Resolves Section 1003(a)(i) and (ii) Deficiencies; Compliance Indicator to Be Removed
SRX Global Reports Paper-Traded EMJX Return of ~25% Since February 11, 2026
EMJX Shifted from “Stress” to “Mixed” for Bitcoin Company Files Updated Investor Presentation Outlining Performance and Strategy Management to Host Fireside Chat Today at 10:30am ET NORTH PALM BEACH, ...
SRX Global Management Team to Host Virtual Fireside Chat on July 14, 2026, and Issues Letter to Shareholders
Virtual Fireside Chat Scheduled for Tuesday, July 14, 2026, at 10:30 a.m. ET Virtual Fireside Chat Scheduled for Tuesday, July 14, 2026, at 10:30 a.m. ET
SRx Global Inc trading halted, news pending
11:41 EDT SRx Global Inc trading halted, news pending
SRx Global board authorizes stock repurchase plan up to 10M shares
SRX Global’s Board of Directors has authorized a share repurchase program under which the Company may repurchase up to 10M shares of its common stock or up to 50% of…
SRX Global Board of Directors Authorizes Stock Repurchase Plan of Up to 10 Million Shares or Up to 50% of its Shares Outstanding
NORTH PALM BEACH, Fla., July 09, 2026 (GLOBE NEWSWIRE) -- SRX Global Inc. (NYSE American: SRXH) (the “Company”, or “SRX”), an AI-enabled platform dedicated to generating long-term shareholder value th...
SRX Global reports preliminary NAV per share of roughly $3.07 as of June 30
SRX Global provided shareholders with a preliminary update on certain balance sheet metrics and its capitalization structure following the recently completed acquisition of EMJX and share consolidatio...
SRx Global Inc trading halted, news pending
13:46 EDT SRx Global Inc trading halted, news pending
SRX Global Reports Preliminary Net Asset Value of Approximately $3.07 Per Share and Over $55 Million in Cash and Short-Term Investments(1)
Approximately $40 million in cash and more than $15 million in short-term investment assets as of June 30, 2026 1
SRX Global Declares One-Time Cash Dividend
NORTH PALM BEACH, Fla., July 08, 2026 (GLOBE NEWSWIRE) -- SRX Global, Inc. (NYSE American: SRXH) (the "Company", or “SRX”), an AI-enabled platform dedicated to generating returns across high-convictio...
SRX Global makes investment in Greenland Mines
SRX Global (SRXH) announced a strategic investment in Greenland Mines (GRML), a critical and precious minerals development company advancing a portfolio of strategic assets in Greenland.
SRX Global Makes Strategic Investment in Critical and Precious Minerals Development Company, Greenland Mines
NORTH PALM BEACH, Fla., July 02, 2026 (GLOBE NEWSWIRE) -- SRX Global, Inc. (NYSE American: SRXH) (the "Company", or “SRX”), an AI-enabled platform dedicated to generating returns across high-convictio...
SRX Global Slides: Investor presentation
SRX Global has posted slides in relation to its latest quarterly earnings report, which was published on June 26, 2026.
SRX Global Announces Share Consolidation
NORTH PALM BEACH, Fla., June 24, 2026 (GLOBE NEWSWIRE) -- SRX Global, Inc. (NYSE American: SRXH) (the "Company", or “SRX”), an AI-enabled platform dedicated to generating returns across high-convictio...
SRx Global Inc trading halted, news pending
16:13 EDT SRx Global Inc trading halted, news pending
SRX Global Makes Strategic Investment in Clinical-Stage Biodefense Company, ARMR Sciences
NORTH PALM BEACH, Fla., June 23, 2026 (GLOBE NEWSWIRE) -- SRX Global, Inc. (NYSE American: SRXH) (the "Company", or “SRX”) today announced a strategic investment in ARMR Sciences, a clinical-stage bio...